Concepedia

Mario Zanfardino

MZ

Statistics

Publications

10

Citations

410

H-Index

10

Active since

2011

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

SDN Istituto di Ricerca Diagnostica e Nucleare

University of Campania "Luigi Vanvitelli"

Federico II University Hospital

University of Naples Federico II

Mario Zanfardino is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in vascular biology, cell death, and inflammation.

ORCID

Top concepts

Publications per year

2011–2022

10

Publications

10

Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression

Carmine Spampanato, S. De Maria, M. Sarnataro et al. · International Journal of Oncology · 2011 · 179 citations · Full text

Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data

Eleonora Riccio, Mario Zanfardino, Lucia Ferreri et al. · European Journal of Human Genetics · 2020 · 62 citations · Full text

The complete 12 Mb genome and transcriptome of Nonomuraea gerenzanensis with new insights into its duplicated “magic” RNA polymerase

Valeria D’Argenio, Mauro Petrillo, Daniela Pasanisi et al. · Scientific Reports · 2016 · 39 citations · Full text

Simvastatin reduces melanoma progression in a murine model

Mario Zanfardino, Carmine Spampanato, Rosanna De Cicco et al. · International Journal of Oncology · 2013 · 26 citations · Full text

, , +16

miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer

Francesco Palma, Alessandra Affinito, Silvia Nuzzo et al. · Cancer Gene Therapy · 2020 · 23 citations · Full text

Rows per page

1–5 of 10